Literature DB >> 34529116

COCH-related autosomal dominant nonsyndromic hearing loss: a phenotype-genotype study.

Kyung Seok Oh1, Daniel Walls2, Richard J Smith3,4,5, Jae Young Choi6, Heon Yung Gee7, Jinsei Jung8,9, Sun Young Joo1, Jung Ah Kim1, Jee Eun Yoo10, Young Ik Koh1, Da Hye Kim10, John Hoon Rim1, Hye Ji Choi10, Hye-Youn Kim1, Seyoung Yu1.   

Abstract

This phenotype-genotype study aimed to investigate the extent of audioprofile variability related to cochlin major domains and to identify potential ethnic-specific differences associated with COCH-related hearing loss. Eight Korean families (26 cases) were diagnosed with COCH-related hearing loss by exome sequencing. Audiometric test results were combined with those from nine published East Asian families (20 cases) and compared with those from 38 European-descent families (277 cases). Audioprofiles were created by grouping audiometric test results into age ranges by age at testing and then averaging hearing loss thresholds by frequency within age ranges. The functional impact of the identified variants was assessed in vitro by examining the intracellular trafficking, secretion, and cleavage of cochlin. In both East Asian and European-descent families segregating COCH-related hearing loss, deafness-associated variants in non-LCCL domains of cochlin were associated with hearing loss that was more severe earlier in life than hearing loss caused by variants in the LCCL domain. Consistent with this phenotypic difference, functional studies demonstrated distinct pathogenic mechanisms for COCH variants in a domain-dependent manner; specifically, a cytotoxic effect was observed for the p.Phe230Leu variant, which is located in the vWFA1 domain. No ethnic-specific differences in hearing loss progression were observed, except for those attributable to an overrepresentation of presymptomatic cases in the European-descent cohort.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34529116      PMCID: PMC8924011          DOI: 10.1007/s00439-021-02368-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  30 in total

1.  Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein.

Authors:  T Ikezono; A Omori; S Ichinose; R Pawankar; A Watanabe; T Yagi
Journal:  Biochim Biophys Acta       Date:  2001-03-26

Review 2.  Profound deafness in childhood.

Authors:  Andrej Kral; Gerard M O'Donoghue
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

Review 3.  Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics?

Authors:  Nele Hilgert; Richard J H Smith; Guy Van Camp
Journal:  Mutat Res       Date:  2008-08-29       Impact factor: 2.433

4.  Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.

Authors:  Seung-Hyun Bae; Nahid G Robertson; Hyun-Ju Cho; Cynthia C Morton; Da Jung Jung; Jeong-In Baek; Soo-Young Choi; Jaetae Lee; Kyu-Yup Lee; Un-Kyung Kim
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

5.  Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment.

Authors:  Sebastien P F JanssensdeVarebeke; Guy Van Camp; Nils Peeters; Ellen Elinck; Josine Widdershoven; Tony Cox; Kristof Deben; Katrien Ketelslagers; Tom Crins; Wim Wuyts
Journal:  Eur J Hum Genet       Date:  2018-02-15       Impact factor: 4.246

6.  Role of protein misfolding in DFNA9 hearing loss.

Authors:  Jianhua Yao; Bénédicte F Py; Hong Zhu; Jianxin Bao; Junying Yuan
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

7.  Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study.

Authors:  H M Fortnum; A Q Summerfield; D H Marshall; A C Davis; J M Bamford
Journal:  BMJ       Date:  2001-09-08

8.  Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss.

Authors:  Moo-Jin Baek; Hyun-Min Park; Justin M Johnson; Cengiz Z Altuntas; Daniel Jane-Wit; Ritika Jaini; C Arturo Solares; Dawn M Thomas; Edward J Ball; Nahid G Robertson; Cynthia C Morton; Gordon B Hughes; Vincent K Tuohy
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

9.  A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutation.

Authors:  E Fransen; M Verstreken; S J Bom; F Lemaire; M H Kemperman; Y J De Kok; F L Wuyts; W I Verhagen; P L Huygen; W T McGuirt; R J Smith; L V Van Maldergem; F Declau; C W Cremers; P H Van De Heyning; F P Cremers; G Van Camp
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

View more
  2 in total

1.  MiR-200c-3p affects cochlear hair cells damaged by oxidative stress via modulating Taok1 expression.

Authors:  Lihua Wu; Ning Yang; Qinghua Liu; Yue Bai; Bo Gao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Clinical Heterogeneity Associated with MYO7A Variants Relies on Affected Domains.

Authors:  Sun Young Joo; Gina Na; Jung Ah Kim; Jee Eun Yoo; Da Hye Kim; Se Jin Kim; Seung Hyun Jang; Seyoung Yu; Hye-Youn Kim; Jae Young Choi; Heon Yung Gee; Jinsei Jung
Journal:  Biomedicines       Date:  2022-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.